Laurion Capital Management LP - PYXIS ONCOLOGY INC ownership

Quarter-by-quarter ownership
Laurion Capital Management LP ownership history of PYXIS ONCOLOGY INC
ValueSharesWeighting
Q3 2023$6,309,898
-22.3%
3,170,8030.0%0.04%
-15.6%
Q2 2023$8,117,256
-36.2%
3,170,8030.0%0.04%
-48.3%
Q1 2023$12,714,920
+199.3%
3,170,8030.0%0.09%
+335.0%
Q4 2022$4,248,876
-32.0%
3,170,8030.0%0.02%
-45.9%
Q3 2022$6,247,000
-17.2%
3,170,8030.0%0.04%
-68.4%
Q2 2022$7,547,000
+53.1%
3,170,803
+159.9%
0.12%
+95.0%
Q1 2022$4,928,000
-61.4%
1,219,832
+4.9%
0.06%
-53.5%
Q4 2021$12,751,0001,162,3320.13%
Other shareholders
PYXIS ONCOLOGY INC shareholders Q4 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,481,662$9,951,4651.48%
Harvest Investment Services, LLC 91,047$365,0980.28%
Tekla Capital Management LLC 708,303$2,840,2950.11%
Laurion Capital Management LP 3,170,803$12,714,9200.09%
Cormorant Asset Management, LP 272,537$1,0930.07%
HHLR ADVISORS, LTD. 530,692$2,128,0750.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 170,295$682,8830.02%
Kingsview Wealth Management, LLC 20,000$80,2000.00%
Point72 Asset Management, L.P. 251,800$1,009,7180.00%
HRT FINANCIAL LP 69,782$2790.00%
View complete list of PYXIS ONCOLOGY INC shareholders